middl
east
respiratori
syndrom
coronaviru
merscov
infect
associ
high
casefat
rate
potenti
pandem
spread
viru
public
health
concern
spike
protein
merscov
merss
facilit
viral
entri
host
cell
depend
activ
merss
cellular
proteas
proteolyt
activ
merss
viral
uptak
target
cell
demonstr
howev
unclear
whether
merss
also
cleav
protein
synthesi
infect
cell
whether
cleavag
requir
merscov
infect
show
merss
process
proprotein
convertas
mersstransfect
merscovinfect
cell
sever
rxxr
motif
locat
border
surfac
transmembran
subunit
merss
requir
effici
proteolysi
howev
blockad
proprotein
convertas
impact
merssdepend
transduct
target
cell
express
high
amount
viral
receptor
modul
merscov
infect
result
show
merss
substrat
proprotein
convertas
demonstr
process
enzym
dispens
protein
activ
effort
inhibit
merscov
infect
target
host
cell
proteas
therefor
focu
enzym
process
merss
viral
uptak
target
cell
emerg
subsequ
pandem
spread
sever
acut
respiratori
syndrom
sar
coronaviru
caus
almost
death
wreak
enorm
econom
havoc
viru
transmit
bat
potenti
via
intermedi
host
human
demonstr
zoonot
transmiss
novel
coronavirus
anim
reservoir
human
pose
signific
threat
public
health
similar
outbreak
scenario
unfold
novel
coronaviru
initi
name
human
coronaviru
emc
term
middl
east
respiratori
syndrom
coronaviru
merscov
detect
patient
jordan
hospit
sever
ultim
fatal
pneumonia
subsequ
viru
spread
within
middl
east
travel
activ
occasion
europ
africa
asia
north
america
outbreak
juli
entail
laboratoryconfirm
infect
death
adapt
viru
moreeffici
humantohuman
spread
public
health
concern
therefor
imper
identifi
explor
novel
target
antivir
therapi
viral
surfac
protein
spike
type
transmembran
protein
synthes
constitut
secretori
pathway
infect
cell
mediat
coronaviru
entri
target
cell
merscov
spike
protein
merss
bind
receptor
surfac
target
cell
drive
fusion
viral
envelop
target
cell
membran
allow
deliveri
viral
protein
rna
host
cell
cytoplasm
site
viral
replic
howev
merss
coronaviru
protein
synthes
inact
precursor
infect
cell
acquir
abil
drive
membran
fusion
upon
process
surfac
unit
transmembran
unit
host
cell
proteas
activ
respons
proteas
essenti
viral
infect
make
enzym
potenti
target
antivir
intervent
demonstr
cystein
proteas
cathepsin
l
type
ii
transmembran
serin
proteas
activ
merss
viral
bind
uptak
target
cell
howev
activ
viral
glycoprotein
includ
activ
protein
certain
strain
coronaviru
infecti
bronchiti
viru
ibv
may
also
proceed
constitut
secretori
pathway
infect
cell
often
accomplish
furin
proprotein
convertas
whether
merss
also
cleav
passag
secretori
pathway
whether
cleavag
event
contribut
protein
activ
present
unknown
show
proprotein
convertas
process
merss
transfect
infect
cell
demonstr
integr
sever
rxxr
motif
locat
border
subunit
requir
protein
process
treatment
merscovinfect
cell
proprotein
convertas
inhibitor
pci
abrog
protein
cleavag
alter
viral
infect
indic
protein
process
infect
cell
dispens
merss
activ
express
plasmid
encod
merss
vesicular
stomat
viru
glycoprotein
vsvg
zair
ebolaviru
glycoprotein
ebovgp
lassa
viru
glycoprotein
lasvgpc
describ
previous
plasmid
e
well
plasmid
encod
merss
ebovgp
ctermin
tag
also
describ
construct
express
lasvgpc
merss
potenti
cleavag
site
mutant
pcm
ctermin
tag
gener
polymeras
chain
reaction
pcr
base
mutagenesi
integr
pcramplifi
sequenc
confirm
autom
sequenc
analysi
cell
propag
dulbecco
modifi
eagl
medium
dmem
life
technolog
supplement
fetal
bovin
serum
fb
panbiotech
penicillin
streptomycin
cell
cultur
dmemglutamax
medium
invitrogen
supplement
fb
penicillin
streptomycin
vero
cell
cultur
dmem
supplement
fb
lglutamin
sodium
pyruv
nonessenti
amino
acid
life
technolog
antibiot
state
cell
line
grown
humidifi
atmospher
co
detect
merss
express
transfect
cell
cell
underw
calcium
phosphat
transfect
respect
plasmid
encod
protein
ctermin
antigen
tag
immunoblot
lysat
separ
sodium
dodecyl
sulfat
gel
electrophoresi
transfer
onto
nitrocellulos
membran
hartenstein
merss
express
detect
use
monoclon
antibodi
direct
tag
invitrogen
polyclon
antibodi
direct
subunit
merss
protein
sino
biolog
detect
merss
protein
infect
cell
vero
cell
infect
merscov
human
betacoronaviru
multipl
infect
moi
respect
hour
infect
cell
harvest
treat
nupag
ld
sampl
buffer
invitrogen
boil
minut
analyz
western
blot
describ
load
control
membran
incub
antibodi
sigma
assess
role
proprotein
convertas
activ
merss
process
transfect
cell
cell
transfect
plasmid
encod
merss
ebovgp
lasvgpc
empti
plasmid
medium
chang
hour
transfect
pci
merck
ad
fresh
medium
indic
concentr
medium
replac
hour
transfect
inhibitor
replenish
cell
lyse
hour
transfect
cleavag
viral
glycoprotein
detect
western
blot
use
monoclon
antibodi
recogn
tag
load
control
antibodi
use
assess
whether
proprotein
convertas
activ
requir
merssdriven
cellcel
fusion
previous
describ
cellcel
fusion
assay
use
base
mix
effector
cell
express
transactiv
target
cell
express
luciferas
control
promot
specif
target
cell
express
merss
glycoprotein
effector
cell
transfect
express
andor
incub
pci
one
day
transfect
cell
mix
allow
cellcel
fusion
medium
supplement
pci
final
concentr
cellcel
fusion
quantifi
determin
luciferas
activ
cell
lysat
hour
cocultiv
use
commerci
avail
kit
pjk
analysi
import
proprotein
convertas
activ
merssdriven
viruscel
fusion
previous
establish
pseudotyp
strategi
use
e
vector
bear
merss
lasvgpc
ebovgp
vsvg
glycoprotein
gener
presenc
absenc
pci
target
cell
cell
transfect
encod
plasmid
empti
plasmid
seed
plate
pretreat
pci
minut
cell
incub
pseudotyp
hour
follow
replac
infect
medium
cultur
medium
contain
inhibitor
transduct
effici
measur
hour
determin
luciferas
activ
cell
lysat
determin
role
proprotein
convertas
activ
infect
authent
merscov
cell
seed
plate
incub
dimethyl
sulfoxid
rise
concentr
pci
hour
inocul
merscov
moi
quadrupl
presenc
inhibitor
incub
minut
cell
wash
incub
cultur
medium
inhibitor
hour
infect
cell
wash
harvest
pellet
lyse
ripa
lysi
buffer
supplement
invitrogen
boil
minut
protein
express
lysat
detect
western
blot
use
polyclon
antibodi
direct
subunit
merss
sino
biolog
parallel
quantif
viral
rna
cell
supernat
dissolv
buffer
machereynagel
rna
extract
follow
quantit
reversetranscript
pcr
analysi
use
upe
assay
previous
describ
quantif
infecti
particl
done
plaqu
assay
use
vero
cell
publish
elsewher
briefli
dilut
supernat
test
duplic
use
cell
monolay
vero
cell
hour
viru
adsorpt
cell
wash
overlay
avicel
resin
day
plate
fix
paraformaldehyd
stain
crystal
violet
solut
investig
influenc
pci
format
merscovinduc
cytopathogen
effect
vero
cell
infect
moi
fix
paraformaldehyd
hour
infect
merscov
antigen
detect
perform
incub
serum
specimen
patient
mer
describ
elsewher
bound
antibodi
detect
cyanin
goatanti
human
immunoglobulin
g
secondari
antibodi
dianova
nuclei
stain
mount
slide
dapi
contain
prolong
gold
antifad
mount
medium
life
technolog
investig
merss
cleavag
viru
produc
cell
determin
whether
protein
cleav
transfect
infect
cell
western
blot
analysi
protein
transfect
cell
merscovinfect
vero
cell
antibodi
specif
subunit
merss
reveal
promin
protein
band
molecular
weight
kda
kda
figur
keep
previou
result
band
correspond
uncleav
merss
presenc
band
indic
effici
process
merss
ntermin
subunit
detect
ctermin
subunit
figur
sever
rxxr
motif
locat
border
subunit
requir
process
merss
inspect
sequenc
locat
border
subunit
merss
reveal
presenc
rxxr
sequenc
figur
might
repres
recognit
site
proprotein
convertas
determin
import
motif
merss
cleavag
chang
arginin
residu
alanin
residu
creat
potenti
cleavag
site
mutant
figur
protein
mutant
express
effici
wildtyp
merss
transfect
cell
figur
except
consist
express
detect
shown
importantli
mutat
potenti
cleavag
site
alon
impact
protein
process
presenc
band
reduc
cell
express
band
molecular
weight
slightli
cell
transfect
plasmid
encod
merss
protein
empti
plasmid
pcdna
vero
cell
either
infect
merscov
multipl
infect
mock
infect
subsequ
cell
lyse
analyz
western
blot
use
polyclon
antibodi
direct
subunit
merss
antibodi
serv
load
control
similar
result
obtain
separ
experi
higher
kda
observ
upon
express
figur
process
compar
seen
merss
wild
type
howev
combin
mutat
potenti
cleavag
site
abrog
protein
process
figur
suggest
also
potenti
cleavag
site
contribut
protein
cleavag
experiment
set
similar
effect
seen
potenti
cleavag
site
simultan
alter
potenti
cleavag
site
mutat
parallel
figur
rxxr
motif
locat
border
requir
effici
process
middl
east
respiratori
syndrom
coronaviru
spike
protein
merss
domain
organ
merss
protein
schemat
depict
merss
sequenc
border
subunit
shown
rxxr
motif
constitut
potenti
cleavag
site
highlight
predict
start
subunit
underlin
mutat
introduc
potenti
cleavag
site
merss
shown
b
cell
transfect
express
plasmid
code
merss
wild
type
indic
merss
mutant
equip
ctermin
tag
transfect
empti
plasmid
pcdna
serv
neg
control
express
protein
cell
lysat
determin
western
blot
use
tagspecif
monoclon
antibodi
express
cell
lysat
assess
load
control
result
shown
repres
least
independ
experi
abbrevi
ct
cytoplasm
tail
pcm
potenti
cleavag
site
mutant
rbd
receptor
bind
domain
sp
signal
peptid
tm
transmembran
domain
collect
result
indic
merss
cleavag
reduc
alter
upon
mutat
potenti
cleavag
site
next
sought
identifi
proteas
respons
merss
cleavag
investig
whether
protein
cleavag
block
cellperm
tripeptid
deriv
contain
argxarg
motiv
known
inhibit
sever
proprotein
convertas
includ
furin
treatment
pci
reduc
product
band
cell
transfect
express
merss
figur
moreov
presenc
pci
diminish
process
zair
ebolaviru
glycoprotein
ebovgp
figur
depend
activ
proprotein
convertas
furin
contrast
process
glycoprotein
lassa
viru
lasvgpc
mediat
proprotein
convertas
suppress
figur
find
keep
known
differ
substrat
specif
thu
inhibitor
sensit
skiisip
compar
proprotein
convertas
specif
basic
amino
acid
like
furin
collect
result
show
activ
proprotein
convertas
essenti
merss
process
transfect
cell
next
assess
whether
proprotein
convertas
activ
requir
proteindriven
cellcel
fusion
use
previous
describ
assay
base
direct
express
protein
receptorproteas
effector
target
cell
respect
express
merss
effector
cell
allow
ineffici
fusion
controltransfect
target
cell
known
express
low
amount
endogen
effici
cellcel
fusion
markedli
increas
target
cell
transfect
andor
encod
plasmid
figur
howev
continu
presenc
pci
target
effector
cell
cultur
mix
appreci
effect
fusion
effici
figur
suggest
proprotein
convertas
activ
dispens
merssdriven
cellcel
fusion
determin
whether
proprotein
convertas
activ
requir
merssdepend
viruscel
fusion
use
previous
report
vector
system
notabl
addit
pci
cell
produc
merssharbor
lentivir
particl
reduc
transduct
target
cell
roughli
figur
contrast
infect
particl
bear
lasvgpc
ebovgp
affect
figur
keep
find
process
lasvgpc
inhibit
pci
figur
process
ebovgp
proprotein
convertas
dispens
gpdriven
viruscel
fusion
note
inhibitori
effect
detect
cell
transfect
express
chosen
target
figur
indic
protein
process
virusproduc
cell
might
dispens
infect
target
cell
express
robust
amount
sum
result
suggest
proprotein
convertas
activ
larg
dispens
merssdriven
cellcel
viruscel
fusion
least
target
cell
produc
high
level
lack
promin
inhibitori
effect
pci
merssdriven
cellcel
viruscel
fusion
might
due
high
level
direct
merss
express
experiment
system
therefor
assess
whether
pci
inhibit
merscov
spread
target
cell
express
endogen
pci
treatment
vero
cell
infect
merscov
inhibit
total
merss
express
reduc
protein
cleavag
effici
concentrationdepend
manner
figur
data
shown
confirm
merss
substrat
proprotein
convertas
infect
cell
howev
pci
treatment
reduc
merscov
propag
determin
amount
viral
rna
figur
data
shown
infecti
unit
figur
data
shown
present
cultur
supernat
similarli
treatment
merscovinfect
cultur
littl
effect
format
cytopath
effect
demonstr
compar
destruct
cell
monolay
figur
thu
process
merss
proprotein
convertas
dispens
merscov
infect
cell
cultur
process
glycoprotein
human
immunodefici
viru
hiv
highli
pathogen
avian
influenza
virus
proprotein
convertas
essenti
viral
infect
consequ
antivir
strategi
aim
inhibit
enzym
develop
result
add
merss
list
proprotein
convertas
substrat
show
sever
rxxr
motif
within
merss
requir
effici
protein
process
howev
activ
proprotein
convertas
dispens
infect
merscov
indic
context
merscov
infect
proprotein
convertas
constitut
target
antivir
intervent
observ
activ
merscov
coronavirus
knock
phenotyp
absenc
infect
defin
target
therapeut
intervent
howev
might
cellular
proteas
constitut
potenti
therapeut
target
context
coronaviru
infect
thu
cleavag
merss
biogenesi
infect
cell
might
requir
subsequ
cleavag
activ
protein
viral
uptak
target
cell
scenario
would
unpreced
given
entri
mediat
glycoprotein
certain
bunyavirus
depend
glycoprotein
process
synthesi
constitut
secretori
pathway
suggest
recent
report
viral
uptak
target
cell
altern
conceiv
process
merss
infect
cell
dispens
viruscel
requir
cellcel
fusion
result
format
syncytia
featur
merscov
pathogenesi
found
merss
effici
although
complet
cleav
proteintransfect
cell
merscovinfect
vero
cell
inhibit
experi
show
proprotein
convertas
activ
essenti
merss
cleavag
find
merss
effici
cleav
transfect
merscovinfect
cell
keep
sever
studi
examin
merss
express
purpos
one
report
show
merss
cleav
transfect
cell
howev
merss
variant
truncat
cytoplasm
tail
examin
conceiv
delet
interf
protein
exposur
recognit
proprotein
convertas
altern
cell
use
protein
express
might
produc
low
amount
proprotein
convertas
robust
protein
process
proprotein
convertas
also
report
mous
hepat
viru
strain
ibv
cleavag
sarss
proteas
ineffici
thu
merss
belong
subgroup
coronaviru
protein
substrat
proprotein
convertas
merss
process
differ
cellular
system
includ
colonderiv
cell
line
robust
proprotein
convertas
cleav
follow
motif
rk
n
stand
amino
acid
find
rxxr
motif
locat
predict
border
subunit
import
merss
process
proprotein
convertas
might
therefor
unexpect
nevertheless
noteworthi
least
rxxr
motif
mutat
parallel
markedli
reduc
protein
process
suggest
process
enzym
recogn
cleavag
site
inde
fragment
produc
upon
cleavag
show
slightli
increas
molecular
weight
rel
fragment
gener
merss
wild
type
would
keep
use
upstream
cleavag
site
like
potenti
cleavag
site
altern
integr
rxxr
motif
locat
border
subunit
might
requir
present
singl
cleavag
site
proteas
sensit
configur
interfer
ebolaviru
glycoprotein
process
proprotein
convertas
compat
robust
viral
spread
vitro
vivo
contrast
proprotein
convertas
activ
requir
full
activ
certain
mhv
ibv
protein
cellcel
viruscel
fusion
reaction
moreov
process
hiv
envelop
protein
proprotein
convertas
essenti
viral
infect
suggest
process
sarss
although
ineffici
still
requir
full
viral
spread
establish
cytopath
effect
infect
cultur
present
studi
provid
evid
effici
blockad
merss
process
pci
appreci
effect
protein
activ
cellcel
fusion
assay
modul
merscov
spread
suscept
cell
contrast
inhibit
merss
process
markedli
reduc
merssdriven
fusion
virion
cell
express
low
amount
endogen
therefor
conceiv
process
merss
proprotein
convertas
requir
optim
spread
merscov
target
cell
express
low
level
scenario
would
keep
observ
ineffici
sarssdriven
cellcel
fusion
due
limit
receptor
express
rescu
direct
express
proteinactiv
proteas
vice
versa
sum
result
identifi
merss
substrat
proprotein
convertas
indic
activ
enzym
dispens
merscov
spread
target
cell
line
potenti
also
infect
human
host
furthermor
find
suggest
mode
protein
activ
might
depend
level
receptor
express
scenario
warrant
analys
